COVID-19

MCB: Still Open for Business

The Division of Molecular and Cellular Biosciences (MCB) would like to assure the scientific community that the Division is still fully operational. MCB is committed to supporting the community and accomplishing the mission of the National Science Foundation (NSF). While Program directors and staff are working virtually during this time, MCB continues to welcome your proposal submissions, participation in MCB’s virtual Office Hours, virtual panel service, and general communications.

The Division understands the immense impact of the COVID-19 pandemic on research, institutional closures, and personal life. If you find yourself struggling to meet a deadline for proposal or award report submissions, please contact your MCB program director. In accordance with NSF Implementation of OMB Memorandum M-20-17, MCB is flexible in considering extensions.

Stay in the loop by regularly checking the NSF coronavirus information page, NSF Twitter page, the BIO Buzz blog for the Directorate for Biological Sciences, and of course subscribe to the MCB Blog.

Please review the Dear Colleague Letter on COVID-19 inviting submissions of Rapid Response Research (RAPID) awards related to the virus. For specific questions or comments, please reach out to an MCB program director.

BIO-wide Virtual Office Hours

As you may have seen, Directorate for Biological Sciences (BIO) Assistant Director Joanne Tornow, PhD, wrote to the biological sciences community to share information about NSF’s current operations in light of COVID-19 and provide guidance to current awardees.

In that letter, Dr. Tornow noted that BIO staff are interested in hearing how BIO and NSF can mitigate the longer-term harm of COVID-19 on U.S. research and training. We will be holding a series of four BIO-wide virtual office hours next week during which the biological science community can share concerns, ask questions, or offer suggestions on how we can do more to address this national emergency.

Sessions dates and times are as follows and registration and log-in information will be available here shortly. Please feel free to attend the session that best fits your schedule; representatives from across BIO will be in attendance during each session.

  • Monday, March 30, 4-5 pm EDT 
  • Tuesday, March 31, 3-4 pm EDT
  • Wednesday, April 1, 2-3 pm EDT
  • Thursday, April 2, 1-2 pm EDT

For more information on NSF’s activities and response to COVID-19, please visit our coronavirus information page; this site is updated regularly.

Dear Colleague Letter on COVID-19

A new Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) (NSF 20-052) invites non-medical, non-clinical-care research proposals that seek to explore how to model and understand the spread of COVID-19; to inform and educate about the science of virus transmission and prevention; and to encourage the development of processes and actions to address this global challenge.

Proposals may be submitted through the Rapid Response Research (RAPID) funding mechanism as well as through existing funding opportunities.

For more information, please read the full Dear Colleague Letter and reference the FAQs. All questions about this DCL should be directed either to a program officer managing an NSF program with which the research would be aligned or to rapid-covid19@nsf.gov.